KF STRIDE to Improve Job Interview Skills

Status Completed

Clinical Trial Summary

The goals of the current study are to evaluate the preliminary effectiveness and feasibility of Kessler Foundation-Strength Identification and Expression (KF-STRIDE) in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU).

Clinical Trial Description

This study will evaluate the acceptability and effectiveness of a strength-based intervention (Kessler Foundation Strength Identification and Expression; KF-STRIDE) that can enhance job interview skills and employment. Despite possessing employable talents, the core social deficits of transition age youth with autism spectrum disorder (TAY-ASD) make it difficult for this group to articulate their individual strengths. This inability to identify and express one's strengths to a potential employer can negatively affect interview performance and lead to difficulty with job obtainment. Thus, the current proposal will examine the effectiveness (Aim 1), acceptability, usability, and feasibility (Aim 2) of a novel strength-based intervention, KF-STRIDE, which is designed to enhance the ability of TAY-ASD to identify personal strengths and effectively discuss them. The goals of the current study are to evaluate the preliminary effectiveness and feasibility of KF-STRIDE in an 8-week randomized controlled trial comparing the intervention to services as usual (SAU). The study will be performed at two private therapeutic schools. Compared to a SAU group, we hypothesize that the KF-STRIDE group will: a) improve the ability to identify strengths (Hypothesis 1), b) improve the ability to express strengths (Hypothesis 2), c) improve other job interview skills (Hypothesis 3) and finally c) improve ability to obtain employment 6-months following the intervention (Hypothesis 4). In this way, the current study is in line with the NIMH's experimental therapeutics model, as we will examine whether the intervention improves employment, as well as identify potential mechanistic targets that could affect outcome. In Aim 2, we will also monitor fidelity, acceptability, usability, and feasibility of the strength-based intervention. The long-term goal of the current research is to collect pilot data that will lead to fully-powered effectiveness and implementation evaluations of KF-STRIDE in other community settings. ;

Study Design

Related Conditions & MeSH terms

Autism Spectrum Disorder

Clinical Trial Details

NCT number	NCT04820647
Study type	Interventional
Source	Kessler Foundation
Contact
Status	Completed
Phase	N/A
Start date	March 29, 2021
Completion date	January 12, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05207956` - App for Strengthening Services In Specialized Therapeutic Support	N/A
Completed	`NCT03286621` - Development of Eye-tracking Based Markers for Autism in Young Children
Completed	`NCT02608333` - Efficiency of Early Intervention for Autism Spectrum Disorder	N/A
Recruiting	`NCT05935722` - Evaluation of a Home-based Parenting Support Program: Parenting Young Children	N/A
Active, not recruiting	`NCT06259539` - A YouTube Curriculum for Children With Autism and Obesity	N/A
Active, not recruiting	`NCT06303791` - Digital-based Psychosocial Intervention for Parents of Children With Neurodevelopmental Disorders	N/A
Enrolling by invitation	`NCT05017779` - A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth	N/A
Completed	`NCT04772898` - Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder	N/A
Recruiting	`NCT04987541` - The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder	N/A
Completed	`NCT04308915` - Mobile-based Games for Cognitive Training in Children With Neurodevelopmental Disorders	N/A
Completed	`NCT06038435` - The Effect of Cognitive Orientation Approach on Daily Occupational Performance With Autism Spectrum Disorder	N/A
Terminated	`NCT04049981` - Investigation of Mechanisms of Action in Superpower Glass	Phase 1/Phase 2
Completed	`NCT03693313` - The Effect of CrossFit Kids on Social Skills in Children With Autism Spectrum Disorder (CrossFit KAMP)	N/A
Recruiting	`NCT04107064` - Achieving Steady Work Among Adults With Autism Through Specialized Employment Program	N/A
Recruiting	`NCT03812068` - Parent-mediated Developmental Behavioral Intervention	N/A
Completed	`NCT03206996` - Exposure Therapy for Auditory Sensitivity in Autism	N/A
Completed	`NCT02299700` - Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder	N/A
Completed	`NCT03422016` - Electroretinogram in Autistic Spectrum Disorders
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Recruiting	`NCT05114538` - Improving the Part C Early Intervention Service Delivery System for Children With ASD	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.